PSA Levels in Men With Spinal Cord Injury and Under Intermittent Catheterization
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
TORRICELLI, Fabio Cesar Miranda
Citação
NEUROUROLOGY AND URODYNAMICS, v.30, n.8, p.1522-1524, 2011
Resumo
Aim: To evaluate serum PSA levels of patients with spinal cord injury (SCI) submitted or not to CIC in comparison to those of the general population. Methods: We retrospectively studied 140 men with SCI admitted in our department from January 2005 to May 2009. Thirty-four SCI patients had PSA levels available, comprising 21 under CIC and 13 without CIC. Patients under CIC performed it 4-6 times a day and mean time of catheterization was 72.4 months (range 30-192). The most common etiology of SCI was fall from height (33%), followed by car/motorcycle crashes (15%). Control group was composed by 670 healthy men that were referred to our service to evaluation of Kidney donation or cancer prostate screening. We used Student's t-test and variance analysis (ANOVA) for age and PSA comparison between the groups. Results: Overall, patients with SCI and controls had similar mean age (54 vs. 57 years old, P = 0.11) and mean PSA level (1.81 vs. 1.95 ng/ml, P = 0.66). SCI patients were divided into with and without CIC. Patients without CIC had similar mean age (60 vs. 57 years old, P 0.11) and similar PSA values when compared to controls (1.72 vs. 1.95 ng/ml, P = 0.89). Patients under CIC were compared to controls with similar age (50 vs. 47 years, P = 0.0332) and their PSA levels were greater (1.86 vs. 0.79 ng/ml, P = 0.026). Conclusion: Clean intermittent catheterization increased PSA levels approximately doubling its value. Neurourol. Urodynam. 30:1522-1524, 2011. (C) 2011 Wiley Periodicals, Inc.
Palavras-chave
clean intermittent catheterization, neurologic bladder, PSA
Referências
- GUESS HA, 1993, UROL CLIN N AM, V20, P627
- PARTIN AW, 1994, J UROLOGY, V152, P1358
- OESTERLING JE, 1991, J UROLOGY, V145, P907
- STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501
- OESTERLING JE, 1993, UROLOGY, V42, P276, DOI 10.1016/0090-4295(93)90616-I
- Batislam E, 1997, UROLOGY, V49, P50, DOI 10.1016/S0090-4295(96)00386-X
- FEERO P, 1990, J UROLOGY, V143, P367
- Konety BR, 2000, UROLOGY, V56, P82, DOI 10.1016/S0090-4295(00)00548-3
- Kravchick S, 2007, J ENDOUROL, V21, P1203, DOI 10.1089/end.2007.9907
- LINDNER A, 1990, J UROLOGY, V144, P1388
- Lynne CM, 1999, J UROLOGY, V162, P89, DOI 10.1097/00005392-199907000-00022
- Matzkin H, 1996, UROLOGY, V48, P63, DOI 10.1016/S0090-4295(96)00087-8
- McNeill SA, 2000, J ROY COLL SURG EDIN, V45, P227
- VESEY SG, 1998, BR J UROL, V62, P347
- Zackrisson B, 2003, UROLOGY, V62, P278, DOI 10.1016/S0090-4295(03)00372-8